Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL?
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL?
Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL? Clin Lymphoma Myeloma Leuk. 2018 02; 18(2):91-97.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
B-Lymphocytes
Gene Expression Profiling
Humans
Lymphoma, Large B-Cell, Diffuse
Prognosis
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-myc
Translocation, Genetic
authors with profiles
Peter Riedell